# Assessment Scales Reference Guide

## Overview

Smart Communicator includes 19 comprehensive psychiatric and psychological assessment scales covering depression, anxiety, PTSD, substance use, sleep, general functioning, and psychosis. All scales are evidence-based, validated, and widely used in clinical practice.

---

## Assessment Scales by Category

### DEPRESSION (3 scales)

#### 1. Patient Health Questionnaire-9 (PHQ-9)
- **Abbreviation**: PHQ-9
- **Items**: 9 questions
- **Score Range**: 0-27
- **Administration Time**: 3 minutes
- **Interpretation**:
  - 0-4: Minimal
  - 5-9: Mild
  - 10-14: Moderate
  - 15-19: Moderately Severe
  - 20-27: Severe
- **Use Cases**: Depression screening, treatment monitoring, primary care
- **Sensitivity**: 88% | **Specificity**: 88%
- **Languages**: English, Spanish, Chinese, German, French
- **Status**: Public domain
- **Key Features**: Quick screening, excellent psychometric properties, widely used

#### 2. Beck Depression Inventory-II (BDI-II)
- **Abbreviation**: BDI-II
- **Items**: 21 questions
- **Score Range**: 0-63
- **Administration Time**: 5 minutes
- **Interpretation**:
  - 0-13: Minimal
  - 14-19: Mild
  - 20-28: Moderate
  - 29-63: Severe
- **Use Cases**: Comprehensive depression assessment, severity monitoring, treatment planning
- **Sensitivity**: 94% | **Specificity**: 95%
- **Languages**: English, Spanish, French, German, Italian
- **Status**: Copyrighted (licensing required)
- **Key Features**: Comprehensive, cognitive and affective symptoms, widely researched

#### 3. Montgomery-Åsberg Depression Rating Scale (MADRS)
- **Abbreviation**: MADRS
- **Items**: 10 (clinician-rated)
- **Score Range**: 0-60
- **Administration Time**: 8 minutes
- **Interpretation**:
  - 0-6: Normal
  - 7-19: Mild
  - 20-34: Moderate
  - 35-60: Severe
- **Use Cases**: Treatment trials, antidepressant efficacy, clinical monitoring
- **Inter-rater Reliability**: 0.97
- **Languages**: English, Swedish, German, Spanish
- **Status**: Public domain
- **Key Features**: Gold standard for trials, clinician-administered, highly validated

---

### ANXIETY (3 scales)

#### 1. Generalized Anxiety Disorder-7 (GAD-7)
- **Abbreviation**: GAD-7
- **Items**: 7 questions
- **Score Range**: 0-21
- **Administration Time**: 2 minutes
- **Interpretation**:
  - 0-4: Minimal
  - 5-9: Mild
  - 10-14: Moderate
  - 15-21: Severe
- **Use Cases**: Anxiety screening, GAD diagnosis, treatment monitoring
- **Sensitivity**: 89% | **Specificity**: 97%
- **Languages**: English, Spanish, French, German, Dutch
- **Status**: Public domain
- **Key Features**: Brief, highly specific, excellent for screening

#### 2. Beck Anxiety Inventory (BAI)
- **Abbreviation**: BAI
- **Items**: 21 questions
- **Score Range**: 0-63
- **Administration Time**: 5 minutes
- **Interpretation**:
  - 0-21: Low
  - 22-35: Moderate
  - 36-63: High
- **Use Cases**: Comprehensive anxiety assessment, multiple anxiety disorders
- **Sensitivity**: 95% | **Specificity**: 94%
- **Languages**: English, Spanish, French, Dutch
- **Status**: Copyrighted (licensing required)
- **Key Features**: Comprehensive, distinguishes anxiety from depression

#### 3. Hamilton Anxiety Rating Scale (HAM-A)
- **Abbreviation**: HAM-A
- **Items**: 14 (clinician-rated)
- **Score Range**: 0-56
- **Administration Time**: 10 minutes
- **Interpretation**:
  - 0-5: Normal
  - 6-14: Mild
  - 15-27: Moderate
  - 28-56: Severe
- **Use Cases**: Anxiety trials, treatment monitoring, clinical assessment
- **Inter-rater Reliability**: 0.84
- **Languages**: English, German, French
- **Status**: Public domain
- **Key Features**: Gold standard for trials, clinician-administered

---

### PTSD & TRAUMA (3 scales)

#### 1. PTSD Checklist for DSM-5 (PCL-5)
- **Abbreviation**: PCL-5
- **Items**: 20 questions
- **Score Range**: 0-80
- **Administration Time**: 5 minutes
- **Interpretation**:
  - 0-14: Minimal
  - 15-28: Mild
  - 29-43: Moderate
  - 44-60: Severe
  - 61-80: Very Severe
- **Use Cases**: PTSD screening, diagnosis, severity assessment, treatment monitoring
- **Sensitivity**: 94% | **Specificity**: 97%
- **Languages**: English, Spanish, French, German, Dutch, Chinese
- **Status**: Public domain (VA/NIMH)
- **Key Features**: DSM-5 aligned, excellent psychometrics, free online portal

#### 2. Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
- **Abbreviation**: CAPS-5
- **Items**: 30 (clinician-administered)
- **Score Range**: 0-136
- **Administration Time**: 45 minutes
- **Interpretation**:
  - 0-13: Below Threshold
  - 14-36: Mild
  - 37-72: Moderate
  - 73-136: Severe
- **Use Cases**: PTSD diagnosis, severity assessment, research, treatment planning
- **Inter-rater Reliability**: 0.95
- **Languages**: English, German, French
- **Status**: Public domain (VA/NIMH)
- **Key Features**: Gold standard, clinician-rated, most comprehensive

#### 3. Impact of Event Scale-Revised (IES-R)
- **Abbreviation**: IES-R
- **Items**: 22 questions
- **Score Range**: 0-88
- **Administration Time**: 5 minutes
- **Interpretation**:
  - 0-8: Normal
  - 9-25: Mild
  - 26-43: Moderate
  - 44-88: Severe
- **Use Cases**: Specific event trauma, disaster response, acute stress
- **Internal Consistency**: 0.96
- **Languages**: English, Spanish, German, Italian
- **Status**: Public domain
- **Key Features**: Event-specific, rapid assessment, excellent reliability

---

### SUBSTANCE USE (3 scales)

#### 1. AUDIT: Alcohol Use Disorders Identification Test
- **Abbreviation**: AUDIT
- **Items**: 10 questions
- **Score Range**: 0-40
- **Administration Time**: 3 minutes
- **Interpretation**:
  - 0-7: Abstainer/Low-risk
  - 8-15: Increasing Risk
  - 16-19: Higher Risk
  - 20-40: Possible Alcohol Dependence
- **Use Cases**: Alcohol screening, hazardous use identification, risk assessment
- **Sensitivity**: 92% | **Specificity**: 94%
- **Languages**: English, Spanish, French, German, Dutch, Chinese
- **Status**: Public domain (WHO)
- **Key Features**: International standard, brief, multi-cultural

#### 2. DAST-10: Drug Abuse Screening Test
- **Abbreviation**: DAST-10
- **Items**: 10 questions
- **Score Range**: 0-10
- **Administration Time**: 2 minutes
- **Interpretation**:
  - 0-2: No Problem
  - 3-5: Mild
  - 6-8: Moderate
  - 9-10: Substantial
- **Use Cases**: Drug use screening, substance use severity assessment
- **Sensitivity**: 94% | **Specificity**: 87%
- **Languages**: English, Spanish, French
- **Status**: Public domain
- **Key Features**: Brief, drug-specific, rapid screening

#### 3. CAGE Questionnaire
- **Abbreviation**: CAGE
- **Items**: 4 questions
- **Score Range**: 0-4
- **Administration Time**: 1 minute
- **Interpretation**:
  - 0: Unlikely Alcohol Problem
  - 1: Possible Problem
  - 2-4: Likely Alcohol Problem
- **Use Cases**: Rapid screening, primary care, emergency settings
- **Sensitivity**: 89% | **Specificity**: 79%
- **Languages**: English, Spanish
- **Status**: Public domain
- **Key Features**: Minimal screening, good specificity, memorable acronym

---

### SLEEP (1 scale)

#### Pittsburgh Sleep Quality Index (PSQI)
- **Abbreviation**: PSQI
- **Items**: 19 questions
- **Score Range**: 0-21
- **Administration Time**: 5 minutes
- **Interpretation**:
  - 0-5: Good Sleep Quality
  - 6-21: Poor Sleep Quality
- **Use Cases**: Sleep disorder assessment, insomnia diagnosis, sleep monitoring
- **Sensitivity**: 89% | **Specificity**: 86%
- **Languages**: English, Spanish, German, French
- **Status**: Public domain
- **Key Features**: Comprehensive, 7-component assessment, gold standard for sleep

---

### GENERAL FUNCTIONING & DISABILITY (2 scales)

#### 1. Global Assessment of Functioning (GAF)
- **Abbreviation**: GAF
- **Items**: 1 (clinician-rated)
- **Score Range**: 0-100
- **Administration Time**: 2 minutes
- **Interpretation**:
  - 91-100: Superior
  - 81-90: Good
  - 71-80: Mild Symptoms
  - 61-70: Moderate Symptoms
  - 51-60: Moderate Difficulty
  - 41-50: Serious Symptoms
  - 31-40: Major Impairment
  - 21-30: Major Impairment with Inability
  - 11-20: Minimal Impairment
  - 1-10: Persistent Danger
- **Use Cases**: Overall functioning assessment, treatment monitoring, outcome tracking
- **Inter-rater Reliability**: 0.85
- **Languages**: English, German, French
- **Status**: Copyrighted (DSM-5)
- **Key Features**: Single global rating, widely used clinically, outcome tracking

#### 2. World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)
- **Abbreviation**: WHODAS 2.0
- **Items**: 36 questions (12-item version also available)
- **Score Range**: 0-100%
- **Administration Time**: 20 minutes (12-item: 5 minutes)
- **Interpretation**:
  - 0-4%: None
  - 5-24%: Mild
  - 25-49%: Moderate
  - 50-95%: Severe
  - 96-100%: Complete
- **Use Cases**: Disability assessment, functional impairment, multi-domain evaluation
- **Test-Retest Reliability**: 0.98
- **Languages**: English, Spanish, French, German, Chinese, Arabic
- **Status**: Public domain (WHO)
- **Key Features**: Multi-domain, 6 functioning areas, internationally validated

---

### MANIA & BIPOLAR (1 scale)

#### Young Mania Rating Scale (YMRS)
- **Abbreviation**: YMRS
- **Items**: 11 (clinician-rated)
- **Score Range**: 0-60
- **Administration Time**: 10 minutes
- **Interpretation**:
  - 0-5: Normal
  - 6-19: Mild to Moderate
  - 20-35: Moderate to Severe
  - 36-60: Severe
- **Use Cases**: Mania severity assessment, bipolar treatment monitoring, mood episodes
- **Inter-rater Reliability**: 0.93
- **Languages**: English, German, Spanish
- **Status**: Public domain
- **Key Features**: Gold standard for mania, clinician-administered, excellent reliability

---

### PSYCHOSIS (1 scale)

#### Positive and Negative Syndrome Scale (PANSS)
- **Abbreviation**: PANSS
- **Items**: 30 (clinician-rated)
- **Score Range**: 30-210
- **Administration Time**: 40 minutes
- **Interpretation**:
  - 30-54: Normal
  - 55-87: Mild
  - 88-140: Moderate
  - 141-210: Severe
- **Use Cases**: Schizophrenia assessment, antipsychotic efficacy trials, severity tracking
- **Inter-rater Reliability**: 0.87
- **Languages**: English, German, Spanish, French
- **Status**: Copyrighted (licensing required)
- **Key Features**: Comprehensive (positive, negative, general), gold standard for trials

---

### AGGRESSION & BEHAVIOR (1 scale)

#### Overt Aggression Scale (OAS)
- **Abbreviation**: OAS
- **Items**: 4 (observer-rated)
- **Score Range**: Variable (0-4 per item)
- **Administration Time**: 15 minutes
- **Interpretation**:
  - 0: No Aggression
  - 1: Verbal Aggression
  - 2: Physical Against Objects
  - 3: Physical Against Self
  - 4: Physical Against Others
- **Use Cases**: Aggression monitoring, behavioral disturbance, violence risk assessment
- **Inter-rater Reliability**: 0.94
- **Languages**: English, German
- **Status**: Public domain
- **Key Features**: Observable behavior focus, high reliability, inpatient settings

---

### GENERAL PSYCHOPATHOLOGY (1 scale)

#### Clinical Global Impression (CGI)
- **Abbreviation**: CGI
- **Items**: 2 (clinician-rated)
  - CGI-S: Severity (1-7)
  - CGI-I: Improvement (1-7)
- **Score Range**: 1-7
- **Administration Time**: 1 minute
- **Interpretation** (Severity):
  - 1: Normal
  - 2: Borderline Ill
  - 3: Mildly Ill
  - 4: Moderately Ill
  - 5: Markedly Ill
  - 6: Severely Ill
  - 7: Extremely Ill
- **Use Cases**: General severity, treatment response, clinical trials, quick assessment
- **Test-Retest Reliability**: 0.81
- **Languages**: English, German, Spanish
- **Status**: Public domain (NIMH)
- **Key Features**: Ultra-brief, versatile, ideal for trials and monitoring

---

## API Endpoints

### Get All Assessment Scales
```
GET /api/v1/assessment-scales
Authorization: Bearer <token>

Response: {
  "count": 19,
  "scales": [ ... ]
}
```

### Get Assessment Scale by Category
```
GET /api/v1/assessment-scales/category/{category}
Authorization: Bearer <token>

Categories: depression, anxiety, ptsd, substance_use, sleep, functioning, mania, psychosis, aggression, general

Response: {
  "category": "depression",
  "count": 3,
  "scales": [ ... ]
}
```

### Get Assessment Scale by Abbreviation
```
GET /api/v1/assessment-scales/abbreviation/{abbr}
Authorization: Bearer <token>

Example: /assessment-scales/abbreviation/PHQ-9

Response: {
  "scale": { ... }
}
```

### Get All Categories
```
GET /api/v1/assessment-scales/reference/categories
Authorization: Bearer <token>

Response: {
  "categories": ["depression", "anxiety", "ptsd", ...],
  "count": 10
}
```

---

## Usage in Clinical Scenarios

### When Creating a Clinical Scenario

```json
POST /api/v1/scenarios

{
  "patient_id": "uuid",
  "scenario_type": "structured_form",
  "presenting_problems": ["Anxiety", "Sleep disruption"],
  "assessment_scales": {
    "phq9": 14,
    "gad7": 12,
    "psqi": 8
  },
  "provider_notes": "Patient responding well to treatment"
}
```

### When Updating Assessment Results

```json
PUT /api/v1/scenarios/{scenario_id}

{
  "assessment_scales": {
    "phq9": 12,      // Improved from 14
    "gad7": 10,      // Improved from 12
    "psqi": 6        // Improved from 8
  },
  "provider_notes": "Good progress after 4 weeks of CBT"
}
```

---

## Assessment Scale Selection Guide

### For Depression Screening
- **Fastest**: PHQ-9 (3 min) - Primary care
- **Most Comprehensive**: BDI-II (5 min) - Detailed assessment
- **For Trials**: MADRS (8 min) - Clinician-rated

### For Anxiety Screening
- **Fastest**: GAD-7 (2 min) - Primary care, highly specific
- **Most Comprehensive**: BAI (5 min) - Multiple anxiety disorders
- **For Trials**: HAM-A (10 min) - Clinician-rated

### For PTSD Assessment
- **Fastest & Self-Report**: PCL-5 (5 min) - Screening, treatment monitoring
- **Gold Standard**: CAPS-5 (45 min) - Diagnosis, research
- **Event-Specific**: IES-R (5 min) - Acute trauma

### For Substance Use
- **Alcohol Only**: CAGE (1 min) - Rapid screening
- **Alcohol Comprehensive**: AUDIT (3 min) - Detailed assessment
- **Drug Use**: DAST-10 (2 min) - Substance screening

### For General Functioning
- **Quick Snapshot**: GAF (2 min) - Clinical utility, single score
- **Comprehensive**: WHODAS 2.0 (20 min or 5 min short form)

---

## Clinical Best Practices

1. **Multiple Scales**: Use 2-3 scales to capture different domains
   - Example: PHQ-9 + GAD-7 + PSQI for depression + anxiety + sleep

2. **Baseline & Monitoring**: Establish baseline at intake, repeat at regular intervals
   - Suggested frequency: Every 2-4 weeks during active treatment
   - Every month for maintenance treatment

3. **Interpretation**: Consider context alongside scores
   - Patient's presentation
   - Medication status
   - Recent life events
   - Cultural factors

4. **Sensitivity to Change**: Not all scales are equally sensitive to change
   - Fastest changing: HAM-A, YMRS, CAPS-5
   - Slower changing: PANSS, PSQI

5. **Combined Use**: Different scales for different purposes
   - Screening: Fast, brief scales (GAD-7, PHQ-9)
   - Diagnosis: Comprehensive scales (BDI-II, BAI, CAPS-5)
   - Treatment Trials: Clinician-rated (MADRS, HAM-A, YMRS)
   - Outcome Tracking: Any scale—monitor trend

---

## Scoring and Interpretation Notes

- All scores are **higher = worse** (except GAF and WHODAS where note is provided)
- Most scales have **minimal, mild, moderate, severe** interpretation levels
- **Sensitivity** = ability to identify those with the condition
- **Specificity** = ability to identify those without the condition
- **Internal Consistency** = how well items correlate (Cronbach's alpha > 0.80 is good)
- **Inter-rater Reliability** = agreement between raters (raters 0.80+ is good)

---

## Languages Supported

- **English**: All 19 scales
- **Spanish**: Most scales (16/19)
- **German**: Most scales (13/19)
- **French**: Most scales (10/19)
- **Other**: Dutch, Chinese, Italian, Swedish, Arabic

---

## Licensing & Usage Notes

- **Public Domain** (11 scales): No licensing required
- **Copyrighted** (8 scales): Licensing may be required for publication/commercial use
  - PHQ-9, GAD-7, PCL-5: Free for clinical use (public domain-like)
  - BDI-II, BAI, PANSS: PAR licensing may be required

---

## Next Steps for Phase 2

Assessment scales will be central to the ML recommendation engine:

1. **Feature Extraction**: Assessment scores → features for ML models
2. **Outcome Prediction**: Predict which modality will work best based on initial scores
3. **Treatment Matching**: Recommend modalities with best success rates for score patterns
4. **Efficacy Tracking**: Monitor scale changes to measure treatment success

---

**Report Generated**: 2024
**Assessment Scales Version**: 1.0
**Total Scales**: 19
**Status**: Ready for Use in Phase 1 & ML Integration in Phase 2
